BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 1, 2014
View Archived Issues
Sumitomo Dainippon Pharma to jointly develop SanBio's stem cell therapy SB-623 for stroke
Read More
Proteome Sciences reports on CKId program and partnership for Alzheimer's diagnostics
Read More
HPP-971, a BACH1 inhibitor with activity in animal models of MS
Read More
Novel potent positive allosteric modulator of nAChRa7 disclosed
Read More
SignaBlok receives NIH grant to develop TREM-1 inhibitors for rheumatoid arthritis
Read More
Aethlon collaborates with Boston University on test for chronic traumatic encephalopathy
Read More
Acasti Pharma reports phase II data for CaPre
Read More
Helsinn reports phase III data for anamorelin in NSCLC patients with anorexia-cachexia
Read More
FDA grants orphan drug status to G-Pump for prevention of chronic severe hypoglycemia
Read More
Abbott acquires Kalo Pharma and CFR Pharmaceuticals to grow Latin American business
Read More
Promising clinical data for vemurafenib plus cobimetinib in BRAF mutation-positive melanoma
Read More
Allosteros Therapeutics divulges novel CaMK-II inhibitors
Read More
Roche discloses new BTK inhibitors
Read More
Novel BACE inhibitors designed at Amgen
Read More
Merck KGaA prepares novel EIF2AK4/GSK-3 inhibitors
Read More
Bristol-Myers Squibb discloses new NS5B inhibitors
Read More
Encouraging data for PD-1 inhibitor pembrolizumab in different PD-L1-positive tumors
Read More
MacroGenics and Takeda enter second DART therapeutics alliance
Read More
MedImmune presents a novel anti-isdH MAb with in vivo activity against S. aureus
Read More
Avedro resubmits NDA for corneal cross-linking system
Read More
FDA awards 15 grants through Orphan Products Grants program
Read More
Preliminary phase I data demonstrates safety of intravitreal AAV2-sFLT01 in patients with AMD
Read More
Eisai plans Aricept filing in China after successful phase III trial in severe Alzheimer's disease
Read More
Johnson & Johnson to acquire Alios BioPharma
Read More
Approval in Japan for manufacturing and distribution of ripasudil hydrochloride hydrate
Read More
Thermo Fisher Scientific, GSK and Pfizer collaborate on oncology companion diagnostics
Read More